Safety and feasibility of radiofrequency ablation for treatment of Bosniak IV renal cysts
Carregando...
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
BRAZILIAN SOC UROL
Autores
YAMANARI, Tassia Regina
REIS, Leonardo Oliveira
Citação
INTERNATIONAL BRAZ J UROL, v.42, n.3, p.456-463, 2016
Resumo
Purpose: To describe our initial experience with radiofrequency ablation (RFA) of Bosniak IV renal cysts. Materials and Methods: From 2010 to 2014, 154 renal tumor cases were treated with percutaneous thermal ablation, of which 10 cases (6.4%) from nine patients were complex renal cysts and were treated with radiofrequency ablation. Results: All complex cysts were classified as Bosniak IV (four women and five men; mean age: 63.6 yrs, range: 33-83 years). One patient had a single kidney. Lesion size ranged from 1.5 to 4.1cm (mean: 2.5cm) and biopsy was performed on four cysts immediately before the procedure, all of which were malignant (two clear cell and two papillary carcinoma). Mean volume reduction of complex cysts was 25% (range: 10-40%). No patients required retreatment with RFA and no immediate or late complications were observed. The follow-up of Bosniak IV cysts had a median of 27 months (interquartile range [IQR], 23 to 38) and no recurrence or significant loss of renal function were observed. Conclusions: Mid-term follow-up of the cases in our database suggests that image-guided percutaneous RFA can treat Bosniak IV cysts with very low complication rates and satisfactorily maintain renal function.
Palavras-chave
Safety, Feasibility Studies, Catheter Ablation, Renal cysts, diabetes syndrome [Supplementary Concept]
Referências
- Allen BC, 2013, AM J ROENTGENOL, V200, P1365, DOI 10.2214/AJR.12.9336
- Brunetti E, 2001, LANCET, V358, P1464, DOI 10.1016/S0140-6736(01)06518-7
- Carrafiello Gianpaolo, 2013, Int J Surg, V11 Suppl 1, pS30, DOI 10.1016/S1743-9191(13)60010-2
- Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46
- Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2
- Felker ER, 2013, AM J ROENTGENOL, V201, P1029, DOI 10.2214/AJR.12.10210
- Harisinghani MG, 2003, AM J ROENTGENOL, V180, P755
- HARTMAN DS, 1986, UROLOGY, V28, P145, DOI 10.1016/0090-4295(86)90109-3
- Huang WC, 2009, J UROLOGY, V181, P55, DOI 10.1016/j.juro.2008.09.017
- Kim PN, 2014, J VASC INTERV RADIOL, V25, P92, DOI 10.1016/j.jvir.2013.09.020
- Kim SD, 2012, KOREAN J RADIOL, V13, P625, DOI 10.3348/kjr.2012.13.5.625
- Kim YS, 2006, THYROID, V16, P361, DOI 10.1089/thy.2006.16.361
- Kunkle DA, 2008, CANCER, V113, P2671, DOI 10.1002/cncr.23896
- Park BK, 2008, EUR RADIOL, V18, P1519, DOI 10.1007/s00330-008-0891-3
- Psutka SP, 2013, EUR UROL, V63, P486, DOI 10.1016/j.eururo.2012.08.062
- Silverman SG, 2008, RADIOLOGY, V249, P16, DOI 10.1148/radiol.2491070783
- Tanagho YS, 2013, J ENDOUROL, V27, P1477, DOI 10.1089/end.2013.0192
- Warren KS, 2005, BJU INT, V95, P939, DOI 10.1111/j.1464-410X.2005.05442.x